Drugs / Liposomal mitoxantrone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05823701 | Sep 2022 → Dec 2023 | diffuse large B-cell lymphoma | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liposomal mitoxantrone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05823701 ↗ |
| Route | Intravenous | “intravenous infusion per cycle” NCT05823701 ↗ |